eHealth in Treatment of Gestational Diabetes (eMOMGDM)

Summary

The overall aim of the eMOM GDM-project is to develop and evaluate a novel system to clinical decision making and patient behavior change in treatment of GDM, combining diet, physical activity, sleep, heart rate (e.g. stress), and glucose monitoring within a single system (the eMOM GDM application), and linking the developed application tool for the normal health care system in a new way.

In this second phase of the project, the effect of eMOM GDM application on maternal and neonatal outcomes will be evaluated in a randomized controlled study design. The follow-up study continues until 3 months postpartum.

Conditions

• Gestational Diabetes
• Mobile Application

Interventions

DEVICE

eMOM GDM application

Participants in the intervention group will use the eMOM GDM -application one week/month. eMOM GDM application includes: * continuous glucose monitor (CGM, Medtronic) * diet (digital food tracker) (min 3 days during one application week) * heartrate, stress and physical activity with the wrist-worn activity tracker (Vivosmart 3) * weight measured once a week The sensors can be worn and the application used during the whole pregnancy (if a mother is interested in)

Sponsors & Collaborators

• University of Helsinki

  collaborator OTHER

• Aalto University

  collaborator OTHER

• UKK Institute

  collaborator OTHER

• Tampere University

  collaborator OTHER

• Finnish Institute for Health and Welfare

  collaborator OTHER_GOV

• Fujitsu

  collaborator UNKNOWN

• Elisa Oyj

  collaborator UNKNOWN

• Business Finland

  collaborator OTHER

• Helsinki University Central Hospital

  lead OTHER

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

45 Years

Sex

FEMALE

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2021-03-10

Primary Completion

2022-12-12

Completion

2026-12-31

Countries

• Finland

Study Locations